Herbalife Ltd (HLF)
(Delayed Data from NYSE)
$8.16 USD
-0.32 (-3.77%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $8.19 +0.03 (0.37%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.16 USD
-0.32 (-3.77%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $8.19 +0.03 (0.37%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
Zacks News
The Zacks Analyst Blog CVS Health, Walgreens and Herbalife
by Zacks Equity Research
CVS Health, Walgreens and Herbalife are included in this Analyst Blog.
What is the Right Approach for CVS Health (CVS) Post Q2 Results?
by Urmimala Biswas
The near-term challenges for CVS Health (CVS) are no doubt worrisome. Yet, the company remains focused on its strategic moves, utilizing integrated healthcare models and technological advancements.
Herbalife Ltd (HLF) Tops Q2 Earnings Estimates
by Zacks Equity Research
Herbalife Ltd (HLF) delivered earnings and revenue surprises of 25.58% and 3.17%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) Stock Pre-Q2 Earnings: To Buy or Not to Buy?
by Urmimala Biswas
CVS Health (CVS) is grappling with a sudden increase in Medicare Advantage members' utilization trend. The Medicaid business, too, is expected to have experienced medical cost pressure in the second quarter.
CVS Health (CVS) Falls 24% in 3 Months: Should You Buy the Dip?
by Urmimala Biswas
While CVS Health (CVS) has been grappling with the pharmacy reimbursement pressure, a turnaround might be in the cards given its several strategic initiatives.
2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry
by Urmimala Biswas
Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.
Herbalife Ltd (HLF) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Herbalife Ltd (HLF) delivered earnings and revenue surprises of 32.43% and 0.66%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Ideas feature highlights: Herbalife and Boeing
by Zacks Equity Research
Herbalife and Boeing have been highlighted in this Investment Ideas article.
Navigate Bearish Markets With This Pattern
by Andrew Rocco
It's critical for investors to recognize bearish patterns to survive downtrending bearish markets. The bear flag pattern is simple and easy to identify, and is the most effective bearish technical pattern.
Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Herbalife and Amazon
by Zacks Equity Research
CVS Health, Walgreens Boots Alliance, Herbalife and Amazon have been highlighted in this Industry Outlook article.
2 Retail Pharmacy Stocks to Watch and One to Avoid Amid Industry Headwinds
by Urmimala Biswas
Zacks Retail-Pharmacies and Drug Stores industry players like CVS and WBA are likely to gain despite reimbursement challenges that are hurting the overall health industry. HLF might face the wrath of economic challenges.
Spotify and Herbalife have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Spotify and Herbalife are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Herbalife (HLF)
by Andrew Rocco
Herbalife's struggles with legal battles, mounting debt, and slowing earnings per share casts a shadow over its future prospects. The company's controversial business model and poor performance suggest ongoing challenges ahead.
Zacks Investment Ideas feature highlights: Coinbase, Super Micro Computer and Herbalife
by Zacks Equity Research
Coinbase, Super Micro Computer and Herbalife have been highlighted in this Investment Ideas article.
Real World vs. Theoretical Investing: Part 2
by Andrew Rocco
Investing in the real-world and investing in theory are worlds apart. Stock Strategist Andrew Rocco provides the details you need to know to succeed and profit in the real-world.
Zacks Investment Ideas feature highlights: Herbalife and GameStop
by Zacks Equity Research
Herbalife and GameStop are part of the Zacks Investment Ideas article.
Shorting: Is the Risk Worth the Reward? (Insights from Market Gurus & the Pitfalls you Need to Avoid)
by Andrew Rocco
On shorter time frames, markets fluctuate, and there is a time to be short. However, investors should focus on long opportunities more often than not as risks are much lower and the risk-to-reward is much more favorable, all else equal.
Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon
by Zacks Equity Research
CVS Health, Herbalife, Rite Aid and Amazon are part of the Zacks Industry Outlook article.
3 Retail Pharmacy & Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
Zacks Retail-Pharmacies and Drug Stores industry players like CVS, HLF and RADCQ are likely to gain despite reimbursement challenges that are hurting the overall industry health.
Is the Options Market Predicting a Spike in Herbalife (HLF) Stock?
by Zacks Equity Research
Investors need to pay close attention to Herbalife (HLF) stock based on the movements in the options market lately.
Herbalife Ltd (HLF) Lags Q3 Earnings Estimates
by Zacks Equity Research
Herbalife Ltd (HLF) delivered earnings and revenue surprises of -13.33% and 4.09%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Lags Q4 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -1.47% and 2.50%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Herbalife (HLF) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Herbalife (HLF) stock based on the movements in the options market lately.
Walgreens (WBA) and VillageMD Expand Partnership in Chicago
by Zacks Equity Research
Walgreens (WBA) and VillageMD's coordinated primary care and pharmacy services are now available in Chicago.
Herbalife Ltd (HLF) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Herbalife Ltd (HLF) delivered earnings and revenue surprises of 13.85% and 4.62%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?